Characteristic |
IBC n =26 (%) |
Non-IBC n =27 (%) |
P-value |
Age
Range
mean |
29-72
51±12.3 |
37-78
55±10.5 |
>0.05 |
Tumor size
≤2
>2
NA |
2 (8%)
23 (92%)
1 |
2 (10%)
20 (90%)
5 |
>0.05 |
Number of Positive Lymph nodes
<4
≥4
NA |
6 (24%)
19 (76%)
1 |
16 (61%)
6 (39%)
5 |
<0.001** |
Tumor grade
Grade I-II
Grade III
NA |
18 (81%)
4 (19%)
4 |
18 (86%)
3 (14%)
6 |
>0.05 |
ER
Negative
Positive
NA |
11 (55%)
9 (45%)
6 |
12 (63%)
7 (37%)
8 |
>0.05 |
PR
Negative
Positive
NA |
9 (45%)
11 (55%)
6 |
12 (63%)
7 (37%)
8 |
>0.05 |
HER-2
Negative
Positive
NA |
14 (82%)
3 (18%)
1 |
15 (79%)
4 (21%)
8 |
>0.05 |
|
| NA = is the number of patients had no available data; n= number of patients; P<0.001 = Extremely significant difference; P>0.05 = non-significant difference |
| Table 1: Clinical and pathological characteristics of IBC and non-IBC patients. |